financetom
Business
financetom
/
Business
/
Artisan says Seven & I independent director resignations show board dysfunction
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Artisan says Seven & I independent director resignations show board dysfunction
Mar 12, 2025 5:27 PM

TOKYO, March 13 (Reuters) - Artisan Partners, a

U.S.-based investor in Japan's Seven & i ( SVNDF ), reiterated

its criticism of governance at the retail giant after two

independent directors resigned on Wednesday, having opposed the

appointment of a new CEO earlier in the week.

"The recent resignations of two of the company's independent

directors are a sign of dysfunction and will serve to further

compromise the board function," Artisan said in a letter.

It follows a separate letter sent on Sunday in which the

activist investor opposed the appointment of Stephen Dacus as

CEO and called for Seven & i ( SVNDF ) to engage with Alimentation

Couche-Tard ( ANCTF ), which is seeking to acquire it.

Foreign investors including Artisan have for some years

pushed the company to focus on its core convenience store

business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exxon group's eighth Guyana project to produce up to 1.5 bcfd of gas
Exxon group's eighth Guyana project to produce up to 1.5 bcfd of gas
Mar 11, 2025
GEORGETOWN, March 11 (Reuters) - The eighth energy project in Guyana of a consortium led by U.S. major Exxon Mobil ( XOM ) will produce up to 1.5 billion cubic feet per day (bcfd) of natural gas and 290,000 barrels per day on condensate through a floating production facility that will have capacity to export the fuel, the group told...
Arvinas, Pfizer Say Vepdegestrant Trial Meets Primary Endpoint in Breast Cancer With ESR1 Mutations
Arvinas, Pfizer Say Vepdegestrant Trial Meets Primary Endpoint in Breast Cancer With ESR1 Mutations
Mar 11, 2025
08:02 AM EDT, 03/11/2025 (MT Newswires) -- Arvinas ( ARVN ) and Pfizer ( PFE ) said Tuesday that a phase 3 clinical trial of vepdegestrant monotherapy as an investigational treatment for advanced or metastatic breast cancer met its primary endpoint in the estrogen receptor 1-mutant population, but did not reach statistical significance in progression-free survival improvement in the intent-to-treat...
RB Global Acquires J.M. Wood Auction
RB Global Acquires J.M. Wood Auction
Mar 11, 2025
08:01 AM EDT, 03/11/2025 (MT Newswires) -- RB Global ( RBA ) said Tuesday it entered into a definitive agreement to acquire J.M. Wood Auction. The transaction is expected to be completed in Q2, subject to customary closing conditions, including required regulatory clearances. Financial terms of the deal were not disclosed. RB Global ( RBA ) said the acquisition of...
Tilray Medical Introduces High THC, High Terpene Genetics to German Medical Cannabis Market
Tilray Medical Introduces High THC, High Terpene Genetics to German Medical Cannabis Market
Mar 11, 2025
08:01 AM EDT, 03/11/2025 (MT Newswires) -- Tilray Medical, a division of Tilray Brands ( TLRY ), (TLRY.TO) on Tuesday said it is introducing in Germany the Tilray Craft brand, a new extension of the Tilray Medical brand. Tilray Craft is being introduced to address the needs of patients in Germany for flower-based medical cannabis with higher THC and higher...
Copyright 2023-2026 - www.financetom.com All Rights Reserved